NU2058 50mg 50mg | Purity Not Available
Adooq Bioscience
NU2058 is a guanine-based CDK inhibitor with IC50 of 17 uM and 26 uM for CDK2 and CDK1.
More Information Supplier PageNU2058 is a guanine-based CDK inhibitor with IC50 of 17 uM and 26 uM for CDK2 and CDK1.
More Information Supplier PageNU2058 is a guanine-based CDK inhibitor with IC50 of 17 uM and 26 uM for CDK2 and CDK1.
More Information Supplier PageNU2058 is a guanine-based CDK inhibitor with IC50 of 17 uM and 26 uM for CDK2 and CDK1.
More Information Supplier PageGSK2256098 is a focal adhesion kinase-1 (FAK) inhibitor with potential antiangiogenic and antineoplastic activities.
More Information Supplier PageGSK2256098 is a focal adhesion kinase-1 (FAK) inhibitor with potential antiangiogenic and antineoplastic activities.
More Information Supplier PageWST-8 is a next generation tetrazolium reagent that serves as a sensitive chromogenic indicator for NADH.
More Information Supplier PageWST-8 is a next generation tetrazolium reagent that serves as a sensitive chromogenic indicator for NADH.
More Information Supplier Page